Saratov JOURNAL of Medical and Scientific Research

The first clinical experience of nanostructured propolis usage in treatment of patients with microbial eczema

Year: 2016, volume 12 Issue: №3 Pages: 500-504
Heading: Dermatovenerology Article type: Case report
Authors: Schnaider D.A., Utz S.R., Zayarskiy D.A., Gus'kova O.P., Gorokhovskiy A.V.
Organization: Saratov State Agrarian University named after N.I. Vavilov, Saratov State Medical University

One of the most common forms of eczema is microbial eczema constituting 12-27% of all the cases of eczema. Application of nanotechnology in the field of medicine, including dermatology and cosmetology continues to increase. An example of innovation, demonstrating the results of research within the chemical technology and practical dermatology and cosmetology is a cosmetic product based on nanostructured systems "core — shell", which is an aqueous dispersion of nanoscale flavonoid "cores", derived from natural propolis which are stabilized by polyelectrolyte "shell". The purpose of this work is to conduct primary research on cosmetic product "Mellisol" on the basis of composite structures "core — shell" stabilized by polyelectrolyte membrane, for its application in the complex therapy in the treatment of microbial eczema. Description of these cases under clinical observation shows high efficacy and safety of cosmetic product "Mellisol" in the treatment of patients with microbial eczema in its acute phase.

1. Shteynlukht ТР. Some pathogenetic differences eczema, atopic dermatitis, and atopic dermatitis. Vestn Dermatol i Venerol 1991; (9): 16-18.
2. Neuber К, Steinrucke К, Ring J. Staphylococcal enterotoxin В affects in vitro Ig E syntheses, interferon-gamma, interleukin-4 and interleukin-5 production in atopic eczema. Biochem Biophys Acta 1995; 107(1-3): 179-182
3. Kanani AS, Sussman GL. The role of infection in atopic dermatitis. J Cutan Med Surg 1999; 3 (2): 29-32
4. Bakulev AL, Kravchenya SS, Murashkin NN, Igonina IA, Epifanova AYu, Slesarenko NA. Microbal eczema: new opportunities combined topical therapy. Vestnik dermatologii i venerologii 2011; (6): 97-98
5. Chernyshev VN, Essel'AE, Lebedenko АА. Characteristic skin microflora at various clinical variants of allergic dermatoses in children. Vestn Dermatol i Venerol 1991; (10): 35-39
6. Suvorova KN, Gukasyan DA. The role of secondary infection in atopic dermatitis. In: 9th all-Union Congress of dermatovenerologists. Moscow, 1991; p. 339
7. Kungurov NV, Evseeva SN, Zakharov MA. Features of a current and therapy of atopic dermatitis in infants. In: 9th all-Union Congress of dermatovenerologists. Moscow, 1991; p. 256
8. Orkin VF. The clinic, epidemiology, pathogenesis, treatment of the Candida infections of the skin and mucous membranes in patients with chronic dermatoses: DSc diss. Saratov, 1992; 332 p.
9. Serbina OP, Chebotarev VV Allergic dermatitis in children: incidence and mechanisms of formation. In: Abstracts of the 8th all-Russia Congress of dermatovenerologists. Moscow, 2001; Vol. 1, p. 69-70
10. Yakovenko GT, Kryazheva VN. Experience in the use of ozone therapy in the treatment of venous leg ulcers. In: Abstracts of the 9th all-Russia Congress of dermatovenerologists. Moscow, 2005; Vol. 2, p. 115
11. Ingberg A., Segal R., Schvill D. The incidence of skin manifestation by dermatophytes in patients with psoriasis. Mycopathologia 1986; 95 (1): 37-39
12. AlievaPM. Epidemiology of atopicdermatitis,immunological mechanisms and predisposition immunocorrective therapy: DSc abstract. Moscow, 1993; 35 p.
13. Karpova NM. The incidence of children allergic dermatoses in environmentally disadvantaged areas. In: Atopic dermatitis in children. Ekaterinburg, 1994; p. 31
14. Molotilov ВА, BorisyukSB. Allergology 2003; (2): 18-21
15. Sokolova TV. Features of the course and management of patients with microbial eczema complicated by candidiasis. Russian Journal of Skin and Veneral Diseases 2007; (1): 13-19
16. Zoirov РТ, Mukhamidieva KM. On the question of treatment of varicose eczema. In: Materials of II Dermatovenerology Congress of Kazakhstan. Almaty, 2000; p. 71
17. Kirilyuk IA, Rasskazova Nl, Pospeeva LA, Afrnas'eva MA, Erina IA. Features of cutaneous microcirculation in patients with eczema. In: Abstracts of the 9th all-Russia Congress of dermatovenerologists. Moscow, 2005; Vol. 2, p. 106
18. SkripkinYuK, KubanovaAA. Ekzema. In:. Skripkin YuK, ed. Skin and Veneral Diseases. Moscow, 2009; p. 220-235
19. Kubanova А.А. Analiz epidemiologicheskoy situatsiipo zabolevaemosti infektsiyami, peredavaemyimi polovyim putem, boleznyam i kozhi, i podkozhnoy kletchatki naseleniya Rossiyskoy Federatsii, po dannyim ofitsialnoy gosudarstvennoy statistiki. Vestnik Dermatologii i Venerologii 2008; (5): 8-18
20. Alekseeva ОК. Carbon nanotubes in biology. PersT 2009; 16 (4): 5-8
21. Ghafari Р, Christine St-DH, Power ME, et al. Impact of carbon nanotubes on the ingestion and digestion of bacteria by ciliated protozoa. Nature Nanotechnology 2008; (3): 347-351
22. Srivastava S, Kotov NA. Composite Layer-by-Layer (LBL) assembly with inorganic nanoparticles and nanowires. Ace Chem Res 2008; 41 (12): 1831-1841
23. Ozin GA, Arsenault AC. Nanochemistry (A Chemical Approach to Nanomaterials). RCS Publishing, 2005; printed by Sun Fung Offset Binding Company Ltd, China; 628 p.
24. Nechaeva OV, Zayarskiy DA, Vakaraeva MM, et al. Study of the biological activity poliazolidinammoniya modified hydrate halogen ions, and modifications thereof against microorganisms. Bulletin of Science and Education Development 2014; (1): 32-36
25. Nechaeva OV, Tikhomirova El, Zayarskiy DA, Vakaraeva MM. Antimicrobial activity poliazolidinammoniya modified hydrate iodine ions. Zhurnal Mikrobiologii, Epidemiologii i Immunobiologii 2015; (3): 88-92
26. Nechaeva OV, Tikhomirova El, Zayarskiy DA, Vakaraeva MM. Creating innovative products based on heterocyclic compounds and poliazolidinammoniya modified hydrate halogen ions. Fundamental Research 2014; (6): 506-511
27. Zayarskiy DA, Portnov SA, Matrosov NA. A process for preparing extracts of vegetable raw materials and products of beekeeping: Patent of the Russian Federation №2446852
28. Shurshalova NF, Nechaeva OV, Vakaraeva MM, et al. Development and testing of laboratory samples of innovative biologically active compounds based on the structure of the "core — shell". Izvestiya of Saratov University. New Series. Series: Chemistry. Biology. Ecology 2015; 15 (3): 76-80
29. Hanifin JM, Thurston М, Omoto М, et al. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group. Exp Dermatol 2001; 10 (1): 11-18.

2016_03-1_500-504.pdf951.95 KB

No votes yet